Thad Wolfram

Thad Wolfram has extensive work experience in various roles within the healthcare and pharmaceutical industries. Thad is currently serving as the President of EmVenio Research. Prior to this, they held leadership positions at Matrix Medical Network, including President of Matrix Clinical Trials and Senior Vice President, Head of Matrix Clinical Trials. Thad also worked at PPD as the Executive Director of Corporate Development and Strategy. Before that, they gained valuable experience at EY Advisory Services as a Senior Manager and Manager in the Life Sciences Advisory Services. Thad also worked as a Principal Consultant and Consultant at PA Consulting Group, specializing in Life Sciences and Healthcare Consulting. Thad started their career in the pharmaceutical industry at Pfizer, where they served as a Scientist in various roles within the Genetically Modified Models Center of Excellence and Cardiovascular and Atherosclerosis Biology divisions. Thad began their professional journey as a Graduate Assistant at Michigan State University and an intern at Pfizer's Veterinary Medicine Biologicals Discovery division. Thad holds a research assistantship at the University of Michigan's Department of Epidemiology.

Thad Wolfram holds an impressive education history. Thad pursued their Bachelor of Science degree in Microbiology and Molecular Genetics at Michigan State University, completing it from 1999 to 2003 at the Lyman Briggs School. In 2004, they went back to Michigan State University, earning a Master of Science degree in Industrial Microbiology / Medical Microbiology, which they completed in 2006. During the same period, from 2004 to 2005, Thad also obtained a Certificate in Business Management and Communication Skills from Michigan State University's Eli Broad College of Business.

Furthering their education, Thad pursued their Master of Business Administration (MBA) with a focus on Innovation and Strategic Management at Rensselaer Polytechnic Institute - The Lally School of Management. Thad enrolled in 2008 and completed their MBA in 2011.

Thad Wolfram's educational background encompasses a range of disciplines, including microbiology, business management, communication skills, and innovation and strategic management.